Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Aldara Imiquimod 5%w/w Topical cream iNova Pharmaceuticals (New Zealand) Limited 3M Health Care (UK) Limited, Loughborough, United Kingdom
|
Product: Active Ingredients:
Dosage Form: New Zealand Sponsor: Manufacturer:
|
Cepacaine Benzocaine 0.4%w/v Cetylpyridinium chloride monohydrate 0.05%w/v Mouthwash Bayer New Zealand Limited Aspen Pharma Pty Limited, Melbourne, Australia
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Keytruda Pembrolizumab 25mg/mL Concentrate for infusion Merck Sharp & Dohme (New Zealand) Limited MSD International GmbH (Ireland), Carlow, Ireland
|
Dated this 23rd day of August 2018.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).